Year 2011

New VP For US Chamber IP Center

The United States Chamber of Commerce Global Intellectual Property Center has announced the addition of an executive vice president, joining from the brand-name pharmaceutical industry.

WHO Members Near Deal On Framework For Influenza Pandemics

World Health Organization members trying this week to agree on elements of a framework for helping the world address the next influenza pandemic headed into the final night of the meeting in intensive negotiations. At press time, negotiations were focused on specifics of standard agreements for the transfer of genetic materials related to flu virus strains.

WTO Members Meet Monday On Geographical Indications Register

World Trade Organization members will meet Monday and Tuesday to discuss an emerging draft text of an agreement that would establish a global register for wines and spirits geographical indications, products named after places with special characteristics, like Bordeaux wine.…

WIPO Hails 2 Millionth International Patent Application

In its slick new office building in Geneva, the World Intellectual Property Organization this week celebrated the 2 millionth patent filing under the Patent Cooperation Treaty, which it manages. In the foyer with white clad windows, a crowd was assembled to hear the praise of the international patent filing system.

Proposals For Single EU Patent Issued; Doubts About EU Patent Court Remain

Legislative proposals for a single European patent emerged from the European Commission this week. If approved by the European Parliament and Council, the measures will make patents granted in one country valid in all participating EU member states and drastically cut the cost of patent protection, the Commission said. Patent lawyers praised the proposals but said the issue of an EU-wide patent litigation court must be resolved first.

Study: Patent Applications Rise On Flu Genetic Resources; Questioning WIPO Report

As a backdrop to World Health Organization members meeting this week in search of a global strategy for future influenza pandemics, the pharmaceutical industry and other actors have been developing a keen interest in patents on influenza genetic resources. A sharp and sustained increase in patent activity on those materials was pointed out by a civil society group in a new report, which it says challenges a recent report by the World Intellectual Property Organization.